Outcome of 2nd Meeting of Implementation and Monitoring Committee
Awaiting price reaction for this filing.
The Implementation and Monitoring Committee of Dharti Proteins Ltd (formerly Devika Proteins Ltd) approved and took on record three sets of financial results on December 27, 2025. These include the audited standalone results for Q4 and FY ended March 31, 2025 (total income Rs 7.20 lakhs, loss of Rs 0.66 lakhs narrowing from Rs 19.01 lakhs loss in FY24), unaudited results for Q1 FY26 ended June 30, 2025 (income Rs 2.29 lakhs, loss of Rs 4.60 lakhs), and unaudited results for Q2/H1 FY26 ended September 30, 2025 (income Rs 0.20 lakhs, loss of Rs 0.42 lakhs). The company is under CIRP, having been admitted by NCLT Ahmedabad on April 29, 2024. The auditor has issued a qualified opinion flagging going concern doubt, long-outstanding loans of Rs 150.46 lakhs that may be irrecoverable, unpaid listing fees, and the company being inoperative with no trading or manufacturing activity.
Shareholders should note this is a distressed company under insolvency resolution with negligible revenue, negative net worth, and a going concern qualification from the auditor. The stock remains high-risk with no operational business and ongoing CIRP proceedings.